Breaking News Instant updates and real-time market news.

SBUX

Starbucks

$66.02

1.32 (2.04%)

11:50
01/22/19
01/22
11:50
01/22/19
11:50

Starbucks option volume 4x normal as shares lift ahead of earnings

Starbucks option volume 4x normal as shares lift ahead of earnings. 30K calls and 20K puts have traded this morning as shares trade up $1.20, or 1.85%, to $65.90 in front of Thursday PM earnings. Straddle pricing in a move near 4%, which is above the 3.1% median but well below last quarters 9.7% jump. Most active this morning is the Feb 67.5 call, with nearly 4K contracts trading in the $1 price range and data suggesting sellers driving the flow.

  • 24

    Jan

SBUX Starbucks
$66.02

1.32 (2.04%)

01/11/19
01/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Asset managers BlackRock (BLK), Eaton Vance (EV), Ivesco (IVZ), Affiliated Managers (AMG) and Legg Mason (LM) downgraded to Hold from Buy at Deutsche Bank, with analyst Brian Bedell saying their fundamentals are "unlikely to improve anytime soon." The analyst believes "investor neglect" toward the stocks should continue on fears of a market downturn, as well as due to poor fundamentals from product outflows and pressure on fee rates and operating margins. 2. Starbucks (SBUX) downgraded to Neutral from Buy at Goldman Sachs by analyst Karen Holthouse, saying she remains "reasonably confident" that Starbucks' initiatives to drive digital engagement can lead to a "more stable" 3%-4% comp trajectory in the U.S. over the next few years. However, its valuation has "rapidly re-rated" to reflect this, and gift cards and digital trends could be points of caution in fiscal Q1. The analyst also downgraded Yum! Brands (YUM) to Sell from Neutral. 3. Gap (GPS) downgraded to Underweight from Overweight at Barclays, with analyst Chethan Mallela saying he believes "challenging" traffic trends and "difficult" comparisons cloud visibility into the company's sales growth momentum. Further, the analyst believes the company's cost pressures will be larger than investors anticipate and pose risk to consensus estimates. 4. WW (WTW) downgraded to Neutral from Overweight at JPMorgan by analyst Christina Brathwaite, saying early in the year channel checks point to a weak start to 2019 for the company. The checks suggest traffic to WW''s website and engagement on its mobile app are down double-digit percentages year-over-year, the analyst added. 5. Hanesbrands (HBI) downgraded to Hold from Buy at Deutsche Bank, with analyst Tiffany Kanaga citing a deep dive of the company's international business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/11/19
BMOC
01/11/19
NO CHANGE
Target $60
BMOC
Market Perform
Starbucks price target lowered to $60 from $63 at BMO Capital
BMO Capital analyst Andrew Strelzik lowered his price target on Starbucks to $60 and kept his Market Perform rating, saying the company's "valuation resiliency" appears to be "disconnected" from changes to the fundamentals. The analyst notes that in spite of trading at "multiyear high relative valuation metrics", Starbucks is facing slower growth and a less solid outlook for its China market. Strelzik adds that although there may not be a near term downside catalyst, the risk-reward on Starbucks appears to be tilted to the downside.
01/11/19
GSCO
01/11/19
DOWNGRADE
Target $68
GSCO
Neutral
Starbucks downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Karen Holthouse downgraded Starbucks to Neutral and lowered her price target for the shares to $68 from $75. The coffee giant closed yesterday up 31c to $64.19. The analyst remains "reasonably confident" that Starbucks' initiatives to drive digital engagement can lead to a "more stable" 3%-4% comp trajectory in the U.S. over the next few years. However, its valuation has "rapidly re-rated" to reflect this, and gift cards and digital trends could be points of caution in fiscal Q1, Holthouse tells investors in a research note. Further, she has "incremental concerns" regarding the China macro environment and the company's comp trajectory in that region. Other consumer companies, like Apple (AAPL) and McDonald's (MCD), have noted weakness in China, the analyst points out. Holthouse this morning also upgraded Texas Roadhouse (TXRH) to Buy from Neutral and downgraded Yum! Brands (YUM) to Sell from Neutral.
12/19/18
JPMS
12/19/18
NO CHANGE
Target $70
JPMS
Overweight
JPMorgan likes shares of Starbucks at current levels
JPMorgan analyst John Ivankoe says he likes shares of Starbucks at current levels after taking a group of investors to the company's Seattle headquarters. Improved visibility into U.S. comp improvement, driven by various sales-driving initiatives along with 6%-7% global unit growth, will allow Starbucks to sustain a premium multiple, Ivankoe tells investors in a research note. He keeps an Overweight rating on the shares with a $70 price target.

TODAY'S FREE FLY STORIES

NICE

Nice Systems

$120.39

1.37 (1.15%)

06:41
03/19/19
03/19
06:41
03/19/19
06:41
Hot Stocks
Nice Systems subsidiary selected by IDB Bank to aid financial crime operations »

Nice Actimize, a Nice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

  • 16

    Apr

  • 16

    Apr

SYK

Stryker

$193.56

-0.43 (-0.22%)

06:39
03/19/19
03/19
06:39
03/19/19
06:39
Recommendations
Stryker analyst commentary  »

Stryker price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDTI

Integrated Device

$48.21

-0.05 (-0.10%)

, SSNLF

Samsung

$0.00

(0.00%)

06:37
03/19/19
03/19
06:37
03/19/19
06:37
Hot Stocks
Integrated Device wireless charging solutions selected by Samsung »

Integrated Device…

IDTI

Integrated Device

$48.21

-0.05 (-0.10%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 25

    Mar

NKE

Nike

$87.80

0.99 (1.14%)

06:36
03/19/19
03/19
06:36
03/19/19
06:36
Recommendations
Nike analyst commentary  »

Nike price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 04

    Apr

  • 04

    Apr

HNHPF

Hon Hai Precision

$0.00

(0.00%)

06:36
03/19/19
03/19
06:36
03/19/19
06:36
Periodicals
Foxconn to establish global data center in Taiwan, DigiTimes reports »

Foxconn Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQB

AquaBounty

$2.79

-0.06 (-2.11%)

06:35
03/19/19
03/19
06:35
03/19/19
06:35
Syndicate
AquaBounty 3.345M share Secondary priced at $2.25 »

H.C. Wainwright acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNR

Denbury Resources

$1.85

0.15 (8.82%)

, PVAC

Penn Virginia

$53.97

1.13 (2.14%)

06:34
03/19/19
03/19
06:34
03/19/19
06:34
Hot Stocks
Denbury Resources and Penn Virginia announce deadline for merger election »

Denbury Resources (DNR)…

DNR

Denbury Resources

$1.85

0.15 (8.82%)

PVAC

Penn Virginia

$53.97

1.13 (2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 17

    Apr

  • 07

    May

FLWS

1-800-Flowers.com

$17.95

-0.09 (-0.50%)

06:34
03/19/19
03/19
06:34
03/19/19
06:34
Upgrade
1-800-Flowers.com rating change  »

1-800-Flowers.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 28

    Mar

TRPX

Therapix Biosciences

$4.55

0.02 (0.44%)

06:34
03/19/19
03/19
06:34
03/19/19
06:34
Hot Stocks
Therapix Biosciences appoints Ambassador Ron Prosor as advisor »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BVN

Buenaventura

$16.76

-0.38 (-2.22%)

06:33
03/19/19
03/19
06:33
03/19/19
06:33
Recommendations
Buenaventura analyst commentary  »

Buenaventura price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

EBS

Emergent BioSolutions

$49.51

-0.43 (-0.86%)

06:31
03/19/19
03/19
06:31
03/19/19
06:31
Hot Stocks
Emergent BioSolutions begins Phase 3 trial to evaluate AV7909 »

Emergent BioSolutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRE

CareTrust REIT

$23.38

-0.49 (-2.05%)

06:31
03/19/19
03/19
06:31
03/19/19
06:31
Hot Stocks
CareTrust REIT increases quarterly dividend 9.8% to 22.5c per share »

CareTrust REIT announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNHPF

Hon Hai Precision

$0.00

(0.00%)

, AAPL

Apple

$188.03

1.83 (0.98%)

06:31
03/19/19
03/19
06:31
03/19/19
06:31
Periodicals
Foxconn aims to finish Wisconsin LCD plant by end of 2020, Reuters says »

Foxconn (HNHPF) has…

HNHPF

Hon Hai Precision

$0.00

(0.00%)

AAPL

Apple

$188.03

1.83 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$37.99

-0.095 (-0.25%)

, LYFT

Lyft

$0.00

(0.00%)

06:31
03/19/19
03/19
06:31
03/19/19
06:31
Periodicals
General Motors mulls options for Lyft stake after IPO, Reuters reports »

General Motors' (GM)…

GM

General Motors

$37.99

-0.095 (-0.25%)

LYFT

Lyft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 30

    Apr

  • 29

    Mar

IMGN

ImmunoGen

$2.59

-0.07 (-2.63%)

, JAZZ

Jazz Pharmaceuticals

$134.45

-2.29 (-1.67%)

06:30
03/19/19
03/19
06:30
03/19/19
06:30
Downgrade
ImmunoGen, Jazz Pharmaceuticals rating change  »

JPMorgan downgrades…

IMGN

ImmunoGen

$2.59

-0.07 (-2.63%)

JAZZ

Jazz Pharmaceuticals

$134.45

-2.29 (-1.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

SBUX

Starbucks

$70.84

0.17 (0.24%)

06:27
03/19/19
03/19
06:27
03/19/19
06:27
Hot Stocks
Starbucks announces enhancements to Starbucks Rewards loyalty program »

Starbucks announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

DPZ

Domino's Pizza

$243.35

-0.895 (-0.37%)

, YUM

Yum! Brands

$100.25

-0.62 (-0.61%)

06:25
03/19/19
03/19
06:25
03/19/19
06:25
Recommendations
Domino's Pizza, Yum! Brands analyst commentary  »

JPMorgan upgrades…

DPZ

Domino's Pizza

$243.35

-0.895 (-0.37%)

YUM

Yum! Brands

$100.25

-0.62 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 01

    May

BCOR

Blucora

$28.33

-0.02 (-0.07%)

06:24
03/19/19
03/19
06:24
03/19/19
06:24
Earnings
Blucora raises Q1 EPS view to $1.41-$1.49 from $1.19-$1.26, consensus $1.25 »

Raises Q1 revenue view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$35.15

0.32 (0.92%)

06:22
03/19/19
03/19
06:22
03/19/19
06:22
Conference/Events
Avis Budget management to meet with Northcoast »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

FIS

FIS

$108.14

-0.73 (-0.67%)

06:22
03/19/19
03/19
06:22
03/19/19
06:22
Downgrade
FIS rating change  »

FIS downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

BLD

TopBuild

$63.98

0.17 (0.27%)

06:22
03/19/19
03/19
06:22
03/19/19
06:22
Downgrade
TopBuild rating change  »

TopBuild downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

F

Ford

$8.57

0.14 (1.66%)

06:21
03/19/19
03/19
06:21
03/19/19
06:21
Periodicals
Ford to increase production rate for U.S. large SUVs, Reuters reports »

Ford's Kentucky…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

ARQL

ArQule

$4.79

0.095 (2.03%)

06:20
03/19/19
03/19
06:20
03/19/19
06:20
Conference/Events
ArQule management to meet with SVB Leerink »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

DB

Deutsche Bank

$9.26

0.375 (4.22%)

06:19
03/19/19
03/19
06:19
03/19/19
06:19
Periodicals
Deutsche Bank loaned over $2B to Trump over two decades, NYT reports »

Before becoming U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFMD

Affimed N.V.

$3.92

-0.08 (-2.00%)

, RHHBY

Roche

$0.00

(0.00%)

06:18
03/19/19
03/19
06:18
03/19/19
06:18
Hot Stocks
Affimed to receive milestone payment under collaboration with Genentech »

Affimed (AFMD) announced…

AFMD

Affimed N.V.

$3.92

-0.08 (-2.00%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.